Osceola Cancer Center is a clinical research site located in Kissimmee, Florida, United States 34741.
Crixeo Health Trust Score: 74/100 (FAIR). This profile has not yet been claimed by the site owner.
Osceola Cancer Center has participated in 7 clinical trials.
Therapeutic areas: Diffuse Large-Cell Lymphoma, Breast Cancer, Multiple Myeloma.
Sponsors: CTI BioPharma, Novartis, Genentech, Inc..
Trust Score: 74/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Osceola Cancer Center has a Crixeo Trust Score of 74/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Osceola Cancer Center has 7 clinical trials on record. Their work covers Diffuse Large-Cell Lymphoma, Breast Cancer, Multiple Myeloma.
Yes — Osceola Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.